Applied Therapeutics Stock (NASDAQ: APLT) stock price, news, charts, stock research, profile.
You can purchase shares of Applied Therapeutics (NASDAQ:APLT) through any online brokerage.
Other companies in Applied Therapeutics’s space includes: Upstream Bio (NASDAQ:UPB), Cogent Biosciences (NASDAQ:COGT), Replimune Group (NASDAQ:REPL), Immatics (NASDAQ:IMTX) and Arcutis Biotherapeutics (NASDAQ:ARQT).
Applied Therapeutics has a consensus price target of $11.04.
The stock price for Applied Therapeutics (NASDAQ: APLT) is $8.84 last updated October 31, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Applied Therapeutics.
Applied Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Applied Therapeutics.
Applied Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.